Syndax Pharmaceuticals Inc (NAS:SNDX)
$ 13.07 -0.24 (-1.8%) Market Cap: 1.12 Bil Enterprise Value: 710.08 Mil PE Ratio: 0 PB Ratio: 3.04 GF Score: 32/100

Syndax Pharmaceuticals Inc at Stifel Virtual Healthcare Conference Transcript

Nov 18, 2020 / 06:20PM GMT
Release Date Price: $22.29 (-1.20%)
Konstantinos Nikolaos Aprilakis
Stifel Financial Corp. - MD & Senior Analyst of Biotech Sector

Good afternoon, and thank you all for joining us. This is Konstantinos Aprilakis. I recently joined the health care equity research team here at Stifel, as a senior biotech analyst. It's my pleasure to introduce Dr. Briggs Morrison, CEO of Syndax. The Syndax team have kindly prepared a brief corporate presentation for us.

Please note that this session will not feature a live Q&A. We ask that you submit any questions for the company directly to our corporate access team via e-mail that can be reached at [email protected]. That's all one word, [email protected]. And with that, I'll turn it over to you, Briggs.

Briggs W. Morrison
Syndax Pharmaceuticals, Inc. - CEO & Director

Thanks so much, Konstantin. Pleasure to be here today to tell you -- bring you up-to-date on where we are in our corporate journey. Let me start with our forward look statement. Again, you can reference our SEC documents to see all the various

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot